INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 260 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2020. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,873,230 | -54.1% | 101,420 | -50.6% | 0.04% | -61.4% |
Q2 2023 | $8,445,675 | +74554.6% | 205,341 | +4.2% | 0.10% | -42.3% |
Q1 2023 | $11,313 | +5.6% | 197,049 | +3.1% | 0.18% | -17.5% |
Q4 2022 | $10,715 | -99.8% | 191,103 | +31.6% | 0.21% | +59.4% |
Q3 2022 | $6,149,000 | -0.7% | 145,161 | +26.6% | 0.13% | -17.9% |
Q2 2022 | $6,195,000 | +26.4% | 114,662 | +50.3% | 0.16% | +40.9% |
Q1 2022 | $4,903,000 | +415.0% | 76,294 | +437.1% | 0.12% | +618.8% |
Q4 2021 | $952,000 | +35.2% | 14,204 | +38.2% | 0.02% | +45.5% |
Q3 2021 | $704,000 | -79.3% | 10,275 | -79.4% | 0.01% | -82.8% |
Q2 2021 | $3,401,000 | +141.4% | 49,845 | +129.7% | 0.06% | +60.0% |
Q4 2020 | $1,409,000 | +33.2% | 21,696 | -3.6% | 0.04% | -23.1% |
Q2 2020 | $1,058,000 | +77.5% | 22,513 | +68.9% | 0.05% | -1.9% |
Q1 2020 | $596,000 | +89.2% | 13,333 | +146.5% | 0.05% | +278.6% |
Q4 2019 | $315,000 | +25.0% | 5,409 | +19.7% | 0.01% | +40.0% |
Q1 2019 | $252,000 | -52.4% | 4,520 | -61.5% | 0.01% | 0.0% |
Q4 2018 | $529,000 | -61.4% | 11,727 | -44.8% | 0.01% | -79.2% |
Q2 2018 | $1,369,000 | +122.2% | 21,257 | +45.3% | 0.05% | +152.6% |
Q1 2017 | $616,000 | -6.8% | 14,629 | +82.7% | 0.02% | +26.7% |
Q3 2016 | $661,000 | +184.9% | 8,005 | +132.6% | 0.02% | +150.0% |
Q1 2016 | $232,000 | -92.6% | 3,442 | -93.5% | 0.01% | -94.3% |
Q3 2015 | $3,145,000 | -77.6% | 52,810 | -74.7% | 0.11% | -74.2% |
Q2 2015 | $14,058,000 | +14.0% | 208,670 | +4.3% | 0.41% | +4.3% |
Q1 2015 | $12,330,000 | +2327.2% | 200,000 | +2036.5% | 0.39% | +2088.9% |
Q4 2014 | $508,000 | +33.0% | 9,361 | +21.6% | 0.02% | +28.6% |
Q3 2014 | $382,000 | +35.5% | 7,700 | +28.3% | 0.01% | +27.3% |
Q2 2014 | $282,000 | -20.3% | 6,000 | -22.1% | 0.01% | -26.7% |
Q1 2014 | $354,000 | -39.7% | 7,700 | -37.4% | 0.02% | -48.3% |
Q4 2013 | $587,000 | +44.2% | 12,300 | +21.8% | 0.03% | +70.6% |
Q3 2013 | $407,000 | -8.9% | 10,100 | -17.2% | 0.02% | -50.0% |
Q2 2013 | $447,000 | – | 12,200 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |